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Abstract Forskolin is a unique structurally complex labdane-type diterpenoid used in the
treatment of glaucoma and heart failure based on its activity as a cyclic AMP booster. Commercial
production of forskolin relies exclusively on extraction from its only known natural source, the plant
Coleus forskohlii, in which forskolin accumulates in the root cork. Here, we report the discovery of
five cytochrome P450s and two acetyltransferases which catalyze a cascade of reactions converting
the forskolin precursor 13R-manoyl oxide into forskolin and a diverse array of additional labdane-
type diterpenoids. A minimal set of three P450s in combination with a single acetyl transferase was
identified that catalyzes the conversion of 13R-manoyl oxide into forskolin as demonstrated by
transient expression in Nicotiana benthamiana. The entire pathway for forskolin production from
glucose encompassing expression of nine genes was stably integrated into Saccharomyces
cerevisiae and afforded forskolin titers of 40 mg/L.
DOI: 10.7554/eLife.23001.001
Introduction
Plants synthesize an impressive diversity of specialized metabolites enabling them to communicate
and adapt to environmental challenges (Mitho¨fer and Boland, 2012; Woldemariam et al., 2011).
Throughout history, humans have benefited from the medicinal properties of many of these phyto-
chemicals (Hardy et al., 2012). Specialized plant metabolites and direct derivatives thereof still con-
stitute more than a third of approved pharmaceuticals (Cragg and Newman, 2013; David et al.,
2015). With over 50,000 known structures according to the ‘Dictionary of natural products’ (http://
dnp.chemnetbase.com/), terpenoids are the largest class of plant specialized metabolites and consti-
tute a vast repository of bio-active natural products including many structurally complex compounds
(Pateraki et al., 2015). Examples of widely used plant-derived terpenoid pharmaceuticals are the
anticancer drug paclitaxel (taxol) (Liu and Khosla, 2010), the therapeutic ingenol mebutate (picato)
that is used for treatment of actinic keratosis (King et al., 2016; Luo et al., 2016) and artemisinin
which is the most efficient treatment against malaria caused by Plasmodium parasites
(Graham et al., 2010; Paddon and Keasling, 2014). Traditional chemical synthesis of plant-derived
diterpenoid pharmaceuticals remains economically challenging, despite recent examples of elegant
strategies mimicking natural routes (Appendino, 2014; Kawamura et al., 2016; Yuan et al., 2016).
Extraction from plant biomass and semisynthesis from biotechnologically produced intermediates
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have been approached as alternative strategies (Graham et al., 2010; Paddon et al., 2013; Rob-
erts, 2007). In contrast to recent examples demonstrating complete pathway reconstruction and
production of opiate alkaloids in yeast (Galanie et al., 2015; Nakagawa et al., 2016), engineered
total biosynthesis of terpenoid therapeutics—including paclitaxel and ingenol esters—has not yet
been achieved. Challenges on the way to achieving this goal include the identification of pathway
enzymes in native systems, particularly for those belonging to multi-enzyme families catalyzing the
biosynthesis of specialized metabolites in plants, engineering of poorly understood multi-step enzy-
matic pathways and difficulties encountered in heterologous expression of key enzymes catalyzing
monooxygenations critical for diterpenoid biosynthesis (Pateraki et al., 2015; Renault et al., 2014).
The diterpenoid forskolin is the active hypotensive principle accumulating in the root cork of
Coleus forskohlii (Pateraki et al., 2014), a perennial shrub of the Lamiaceae family, indigenous to
India and Southeast Asia with numerous reported applications in traditional medicine (Alasbahi and
Melzig, 2010b; Kavitha et al., 2010). The pharmaceutical properties of forskolin are based on its
ability to directly activate the adenylate cyclase enzyme resulting in elevated levels of the second
messenger cyclic adenosine monophosphate (cAMP) (Doseyici et al., 2014; Seamon et al., 1981).
Approved applications of forskolin range from alleviation of glaucoma (OcuforsEye drop solutions,
Sabinsa, India), treatment of hypertension and heart failure (Colforsin daropate hydrochloride, a
water-soluble derivative of forskolin, Nippon Kayaku, Japan) to lipolysis and body weight control
(Godard et al., 2005; Kikura et al., 2004; Toya et al., 1998; Wagh et al., 2012; Yoneyama et al.,
2002). Therapeutic opportunities were also suggested in animal tests, where forskolin-induced pig-
mentation of the skin, increasing protection against UV-associated carcinogenesis (D’Orazio et al.,
2006). The complex chemical structure of forskolin with a decalin core, characteristic of labdane-
type diterpenoids, a tetrahydropyran ring, five oxidized positions and eight chiral centers
(Figure 1A) represents a challenge for classical organic chemical synthesis, although a key
eLife digest Unlike animals, plants cannot move away from a herbivore or other threats.
Instead, they have evolved to produce a vast array of chemical compounds to protect themselves.
Some of these compounds are also important to humans, for example, as medicines or fragrances.
Plants usually only produce small amounts of these compounds in mixtures with many other
compounds, which makes it difficult to purify them. As a result, the methods of purifying the
compounds may require huge amounts of plant material, or be expensive and not environmentally
friendly. One solution to this would be to genetically engineer microbes like bacteria or yeast to
produce the compounds instead. In order to do that, we need to understand exactly which enzymes
the plant uses to make each compound and introduce them into suitable microbes.
A compound called forskolin has been used since ancient times in traditional Indian medicine to
treat conditions like high blood pressure, asthma and heart complications. Forskolin is found
exclusively in the root of a plant called Coleus forskohlii, which is native to India and south-east Asia.
It is stored inside cells within the bark of the root in structures called oil bodies, which are similar to
oil drops. However, it is not known where forskolin is made, or which enzymes are involved.
Pateraki, Andersen-Ranberg et al. set out to uncover how C. forskohlii produces this compound.
The experiments show that forskolin is produced within the cells that contain the oil bodies. A
technique called RNA sequencing was used to identify several genes that are highly active in these
cells and encode enzymes that could potentially be involved in producing forskolin. Further
experiments demonstrated that these enzymes drive a cascade of chemical reactions that convert a
molecule called 13R-manoyl oxide into forskolin. Next, Pateraki, Andersen-Ranberg et al. inserted
the genes into yeast cells that could already produce 13R-manoyl oxide, which allowed the yeast to
produce relatively high amounts of forskolin.
These findings show that it is possible to identify the genes involved in the production of
medicinal compounds in a relatively short amount of time. This knowledge will aid the development
of a method that can be used to produce forskolin and other similar compounds on a large scale
without needing to harvest C. forskohlii plants.
DOI: 10.7554/eLife.23001.002
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intermediate for stereoselective total synthesis has been reported (Ye et al., 2009). Hence, commer-
cially available forskolin is extracted from C. forskohlii roots and purified from a mixture of over 60
structurally related abietane and epoxylabdane diterpenoids with a forskolin content varying from
0.013% to 0.728% of root dry weight (Alasbahi and Melzig, 2010a; Asada et al., 2012;
Srivastava et al., 2017). As the demand for forskolin grows, reliable and sustainable commercial
production from C. forskholii will become unachievable due to low yields, susceptibility of this
Figure 1. Biosynthesis of forskolin in the root cork cells of C. forskohlii. (A) Scheme showing the structures of the diterpene precursor 13R-manoyl
oxide, deacetylforskolin and forskolin on a background of root cork cells with forskolin containing oil bodies. (B) Transcript profiles of biosynthetic
candidate genes in selected tissues of C. forskohlii as shown on the illustrations.
DOI: 10.7554/eLife.23001.003
The following source data is available for figure 1:
Source data 1. cDNAs identified in the C. forskohlii root cork transcriptome and cloned during this work, with the GeneBank accession numbers.
DOI: 10.7554/eLife.23001.004
Source data 2. Table of FPKM (Fragments Per Kilobase of transcript per Million mapped reads) values of the first 20 most abundant cDNAs identified
in the root cork transcriptome library.
DOI: 10.7554/eLife.23001.005
Source data 3. Table of primers used in this study.
DOI: 10.7554/eLife.23001.006
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species to diseases, changing climatic conditions and the resource intensive extraction and purifica-
tion procedure required to obtain pharmaceutical grade forskolin (Mora-Pale et al., 2014). Elucida-
tion of the biosynthetic pathway to forskolin and subsequent engineering of the pathway into
microbial hosts offers a more clear and stable alternative production system that will be better able
to address future needs.
Recently, we reported specific accumulation of forskolin and its diterpene scaffold 13R-manoyl
oxide in the root cork cells of C. forskohlii. A pair of diterpene synthases (CfTPS2 and CfTPS3), exclu-
sively present in the root cork, was found to catalyze cyclization of the C20 diterpenoid precursor
geranylgeranyl diphosphate (GGPP) into 13R-manoyl oxide, the diterpene scaffold of forskolin
(Pateraki et al., 2014). As a proof of concept, biosynthesis of 13R-manoyl oxide in enantiomerically
pure form but in low yields was achieved by expressing CfTPS2 and CfTPS3 in Saccharomyces cerevi-
siae, E. coli and Synechocystis sp. (Andersen-Ranberg et al., 2016; Englund et al., 2015;
Nielsen et al., 2014). Taking into account the functionalization steps needed for conversion of 13R-
manoyl oxide to forskolin (Figure 1A), involvement of enzymes from the families of cytochrome
P450s (CYPs) and acetyltransferases was predicted.
Here, we report an integrated biochemical and functional genomics approach, including metabo-
lomics, single-cell-type transcriptome studies and a synthetic biology modular approach involving
transient combinatorial expression of candidate genes in Nicotiana benthamiana to identify the
panel of enzymes catalyzing functionalization of the C. forskohlii diterpene backbones and more spe-
cifically the biosynthesis of forskolin. Pathway intermediates were identified using GC- or HPLC-
HRMS-SPE-NMR. To demonstrate the downstream application of the present work regarding bio-
technological production of forskolin, the entire forskolin biosynthetic pathway was reconstituted in
engineered S. cerevisiae for fermentation-based production of forskolin from glucose. Forskolin is
the first example of a pharmaceutical diterpenoid produced entirely in yeast at titers relevant for
industrial consideration. The outlined combinatorial biochemistry approach paves the way for devel-
opment of yeast-engineered platforms for biosynthesis of other known or new-to-nature
diterpenoids
Results
Discovery of multifunctional cytochromes P450 in Coleus forskohlii
producing a multitude of 13R-manoyl oxide-derived diterpenoids and
identification of a biosynthetic pathway for forskolin
The conversion of 13R-manoyl oxide to forskolin requires six regio- and stereospecific monooxyge-
nations and a single regiospecific acetylation (Figure 1A). Considering the strict localization of for-
skolin in the root cork cells of C. forskohlii and the almost exclusive expression of the pair of
diterpene synthases forming 13R-manoyl oxide within the same tissue (Pateraki et al., 2014), the
root cork was selected for deep RNA-Seq transcriptome analysis. The generated transcriptome con-
tained 263,652 assembled putative cDNAs. The transcriptome was queried for transcripts encoding
CYPs belonging to the CYP71 clan, based on their established role in monooxygenation reactions in
the biosynthesis of specialized metabolites (Nelson, 2013; Werck-Reichhart and Feyereisen,
2000). Their relative levels in the root cork transcriptome were also taken into consideration. Within
the CYP71 clan, focus was also placed on P450 subfamilies that showed extensive, recent expansions
in the cork transcriptome (Nelson and Werck-Reichhart, 2011; Werck-Reichhart and Feyereisen,
2000). Members of the CYP76AH subfamily, part of the CYP71 clan, have recently been shown to
catalyze monooxygenation of abietane-type diterpenoids like miltiradiene and dehydroabietadiene
in Lamiaceae species, closely related to C. forskohlii (Bozˇic´ et al., 2015; Ignea et al., 2016a; Zi and
Peters, 2013). Members of this P450 subfamily were therefore of high interest as enzymes putatively
involved in diterpenoid biosynthesis in C. forskohlii. Based on these considerations, a total of 29
CYP candidates (Figure 1—source data 1) were selected and cloned in full length using as template
cDNA synthesized from root cork total RNA. Among these CYPs, seven members were assigned to
the CYP76AH subfamily by the ‘P450 Nomenclature committee’ (Nelson, 2009), rendering this CYP
subfamily the highest represented in the transcriptome (Figure 1—source data 1). Five were full
length sequences (CfCYP76AH8, CfCYP76AH9, CfCYP76AH10, CfCYP76AH11, and CfCYP76AH11),
whereas two (CfCYP76AH15 and CfCYP76AH16) were represented by partial cDNAs. For the latter,
Pateraki et al. eLife 2017;6:e23001. DOI: 10.7554/eLife.23001 4 of 28
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5’RACE experiments afforded the full-length cDNAs. Similarly to the previously identified diTPSs,
CfTPS2 and CfTPS3 (Pateraki et al., 2014), gene expression studies showed that the identified
members of the CYP76AH family were highly or exclusively expressed in the root cork cells
(Figure 1B).
We have recently reported an Agrobacterium-mediated modular transient expression system in
N. benthamiana enabling biosynthesis of labdane-type diterpenes in quantities permitting purifica-
tion and structural elucidation (Andersen-Ranberg et al., 2016). Utilizing this system, all candidate
P450 genes were heterologously expressed in combination with genes necessary for the production
of high amounts of 13R-manoyl oxide (Andersen-Ranberg et al., 2016; Pateraki et al., 2014). Of
the CYPs tested, six efficiently converted 13R-manoyl oxide into oxygenated derivatives (Figures 2A
and 3 and Figure 3—figure supplements 1 and 2). CfCYP76AH15, CfCYP76AH8 and CfCYP76AH17
catalyzed formation of 11-oxo-13R-manoyl oxide (2) as the main product (Figures 2 and 3). Forskolin
harbors a keto-group at the C-11 position, like the majority of 13R-manoyl oxide-derived diterpe-
noids found in C. forskohlii (Asada et al., 2012; Zhang et al., 2009). Of the three CfCYP76AHs
tested in this experiment, CfCYP76AH15 showed the highest efficiency and specificity for the
Figure 2. 13R-manoyl oxide oxide-derived hydroxylated products formed following transient expression of CfCYP76AHs in N. benthamiana leaves. (A)
Molecular formulas of the hydroxylated products obtained using different CfCYP76AHs. The number of hydroxylations of each compound was deduced
from its accurate molecular mass (<5 ppm, Supplementary file 1) as determined by LC-qTOF-MS or NMR. Each different compound is marked by a
number. (B) Chemical structures of the compounds marked with numbers in bold in A as determined by NMR (Tables 1 and 2). MO: manoyl oxide
DOI: 10.7554/eLife.23001.007
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conversion of 13R-manoyl oxide to 2 with no concomitant formation of multi-oxygenated products
(Figure 2). Compound 5d produced by CfCYP76AH8 as well as by CfCYP76AH17 was identified as
1,11-dihydroxy-13R-manoyl oxide (Figures 2B and 4 and Tables 1 and 2). Noticable, this specific
oxygenation pattern is found in forskolin. Minor amounts of several di- and trihydroxylated 13R-
manoyl oxide-derived compounds were also produced by CfCYP76AH8 and CfCYP76AH17
(Figure 2A and Figure 3—figure supplement 1). Although we managed to identify the chemical
structures of a number of 13R-manoyl oxide derivatives (Figure 2B), it was not possible to do so for
all the compounds shown in Figure 3—figure supplement 1. The main obstacle was the high com-
plexity as well as the small amounts of the diterpenoids produced in N. benthamiana leaves express-
ing the CfCYP76AHs. Additional limiting factors were the instability of several of these compounds
and the limiting plant material available. Production of higher amounts of these compounds in
microbial hosts was not pursued, because the terpenoid profiles observed following expression of
the enzymes in plants and yeast cells were not identical.
Two additional CYPs of the CYP76AH subfamily catalyzed oxygenation of 13R-manoyl oxide at
different positions without substantial formation of C-11 keto derivatives. CfCYP76AH16 yielded
predominantly 3a which was identified by NMR as 9-hydroxy-13R-manoyl oxide (or coleorol) and
CfCYP76AH11 produced a range of monooxygenated derivatives including traces of 10b which was
identified by NMR as 9-deoxydeacetylforskolin (Figure 2). The positions of the carbonyl and
Figure 3. GC-MS analysis of 13R-manoyl oxide (1) derived diterpenoids obtained by transient expression of CYP76AHs from C. forskohlii in N.
benthamiana leaves. (A) GC-MS total ion chromatograms (TIC) of extracts from N. benthamiana transiently expressing CfCXS, CfGGPPS, CfTPS2 and
CfTPS3 (13R-manoyl oxide biosynthesis) genes in combination with water (-), CfCYP76AH15, CfCYP76AH17, CfCYP76AH8, CfCYP76AH11 or
CfCYP76AH16. 1-eicosene was used as internal standard (IS). 13R-manoyl oxide (1) was identified only in (-), indicating that it is further metabolized by
the CfCYP76AH15, CfCYP76AH17, CfCYP76AH8, CfCYP76AH11 and CfCYP76AH16 enzymes. (B) m/z spectrum of 11-oxo-13R-manoyl oxide (2). (C) m/z
spectrum of 9-hydroxy-13R-manoyl oxide (3a). The structure of both compounds was verified by NMR analysis (Tables 1 and 2). The compounds have
been identified previously in C. forskohlii as putative intermediates in the in planta biosynthesis of forskolin (Asada et al., 2012). For each combination,
extracts from leaves of three different N. benthamiana plants have been analyzed and representative chromatograms are shown.
DOI: 10.7554/eLife.23001.008
The following figure supplements are available for figure 3:
Figure supplement 1. LC-qTOF-MS analysis of 13R-manoyl oxide-derived diterpenoids obtained by transient expression of C. forskohlii CYP76AH
encoding genes in N. benthamiana leaves.
DOI: 10.7554/eLife.23001.009
Figure supplement 2. GC-MS analysis of 13R-manoyl oxide-derived diterpenoids following transient expression in N. benthamiana leaves of the C.
forskohlii gene encoding CfCYP71D281 together with genes encoding the required enzymes for biosynthesis of 13R-manoyl oxide (CfCXS, CfGGPPS,
CfTPS2, CfTPS3).
DOI: 10.7554/eLife.23001.010
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hydroxyl-groups in 3a and 10b were consistent with those in forskolin. Thus, the individual activities
of the CYPs catalyzing formation of these compounds can be considered complementary in forskolin
biosynthesis: 10b carries the carbonyl-function at C-11 and the three hydroxyl groups observed in
forskolin at positions C-1, C-6 and C-7, but lacks hydroxylation at the C-9 position, which is observed
in 3a. The only enzyme outside the CYP76AH subfamily that displayed activity toward 13R-manoyl
oxide was CYP71D381, which resulted in oxidized derivatives at positions not compatible with for-
skolin (Figure 3—figure supplement 2).
To probe the role of the different CfCYP76AH enzymes in forskolin biosynthesis, they were co-
expressed by combining one of the three P450s catalyzing formation of 2 with the functionally dis-
tinct CfCYP76AH11 and CfCYP76AH16, first in pairs, then in all possible permutations as triplets
(Figure 5 and Figure 5—figure supplement 1). The combination of CfCYP76AH15 and CfCY-
P76AH11 afforded production of 6,7-dihydroxy-11-keto-manoyl oxide (7h) as part of a complex mix-
ture. Formation of 7h demonstrated combined introduction of the carbonyl group at C-11 together
Figure 4. Structures of key compounds presented in this work. (A) Compounds confirmed using authentic standards. (B) Compounds which structure
was confirmed/identified by comparison of 13C NMR data with existing literature. (C) Compounds which structure was confirmed/identified by HMBC
and NOE correlations for assigning position of OH-groups (marked in red), whereas couplings identified in the previously uncharacterized compounds
3b, 3c and 5d are marked in black. All other molecular structures were confirmed by 13C chemical shifts in comparisons to reference values (Table 1,
Figure 4—source data 1).
DOI: 10.7554/eLife.23001.011
The following source data is available for figure 4:
Source data 1. NMR spectra’s of selected 13R-manoyl oxide derived molecules.
DOI: 10.7554/eLife.23001.012
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with two hydroxyl groups at positions C-6 and C-7, again consistent with the oxygenation pattern of
forskolin (Figure 2 and Figure 5—figure supplement 1).
When the CfCYP76AH enzymes were assayed in triplet combinations, the product profiles were
further shifted towards multi-oxygenated 13R-manoyl oxide derivatives. The formation of minor
amounts of deacetylforskolin (13b) and several compounds with identical mass to charge ratio (m/z)
but different retention times were detected using different enzyme combinations (Figure 5,
Supplementary file 1). The triplet combination CfCYP76AH15, CfCYP76AH11 and CfCYP76AH16
led to the highest amounts of 13b. Thus, this combination of multifunctional P450s appeared to con-
stitute the optimal biosynthetic pathway for specific formation of 13b from 1 (Figure 5).
Table 1. 1H-NMR and 13C-NMR chemical shifts (Figure 4—source data 1) of novel oxygenated 13R-(+)-manoyl oxide-derived diterpe-
noids formed following transient expression of CYP encoding genes from C. forskohlii.
19-hydroxy-
13R-manoyl oxide (3c)*
2-hydroxy-
13R-manoyl oxide (3b)*
1,11-dihydroxy-
13R-manoyl oxide (5d)*
Pos. 1H (nH; m; J(Hz)) 13C 1H (nH; m; J(Hz)) 13C 1H (nH; m; J(Hz)) 13C
1 0.89 (1H;m)
1.63 (1H; m)
39.1 1.10 (1H; t(br); 11.9, 11.9)
1.77 (1H; m)
51.3 3.49 (1H; dd;11.1, 4.5) 79.0
2 1.44 (1H; m)
1.56 (1H; m)
18.1 3.92 (1H; m) 65.3 1.75 (1H; td; 13.5, 11.1, 3.9)
1.60 (1H; m)
29.0
3 0.95 (1H; m)
1.78 (1H; m)
35.8 0.76 (1H; t(br); 11.9, 11.9)
1.99 (1H; d(br); 11.9)
48.2 1.47 (1H; dd; 13.6, 3.9)
1.39 (1H; td; 13.5, 3.6)
39.6
4 38.5 34.9 33.4
5 1.10 (1H; dd; 2.3, 12.6) 56.9 0.95 (1H; dd; 2.2, 12.4) 55.9 0.84 (1H; dd; 11.3, 2.0) 55.6
6 1.36 (1H; dd; 3.6, 12.6) 20.1 1.68 (1H; m) 19.7 1.47 (1H; m) 20.2
1.75 (1H; m) 1.27 (1H; m) 1.64 (1H; m)
7 1.42 (1H; m)
1.83 (1H; dt; 3.3, 12.2)
43.6 1.45 (1H; dd(br); 3.6, 12.5)
1.85 (1H; dt(br); 2.9, 12.5)
43.2 1.48 (1H; m)
1.85 (1H; m)
44.0
8 75.1 75.1 75.3
9 1.35 (1H; dd; 4.3, 12.0) 55.7 1.40 (1H; dd; 4.2, 11.9) 55.4 1.54 (1H; d; 5.8) 55.8
10 37.3 38.7 43.8
11 1.48 (1H; m)
1.58 (1H; m)
15.4 1.53 (1H; m)
1.61 (1H; m)
15.6 4.38 (1H; br q; » 8.6) 65.6
12 1.78 (1H; m)
1.64 (1H; m)
35.7 1.78 (1H; m)
1.66 (1H; m)
35.5 2.02 (1H; dd; 14.3, 8.7)
2.27 (1H; dd; 14.3, 8.7)
35.8
13 73.4 73.4 72.8
14 5.87 (1H; dd; 10.8, 17.4) 147.7 5.87 (1H; dd; 10.8, 17.4) 147.7 5.90 (1H; dd; 17.4, 10.8) 147.1
15 4.92 (1H; dd; 1.5, 10.8)
5.14 (1H; dd; 1.5, 17.4)
110.2 4.92 (1H; d; 10.8)
5.14 (1H; d; 17.4)
110.3 4.94 (1H; dd; 10.7, 1.5)
5.17 (1H; dd; 17.4, 1.5)
111.2
16 1.27 (3H; s) 28.5 1.27 (3H; s) 28.7 1.27 (3H; s) 32.1
17 1.28 (3H; s) 25.3 1.29 (3H; s) 25.7 1.49 (3H; s) 27.8
18 0.97 (3H; s) 26.8 0.93 (3H; s) 33.5 0.78 (3H; s) 13.5
19 3.70 (1H; d; 10.9)
3.46 (1H; d; 10.9)
65.4 0.85 (3H; s) 22.2 0.85 (3H; s) 32.8
20 0.78 (3H; s) 15.7 0.84 (3H; s) 16.5 0.79 (3H; s) 21.1
* 1H and 13C NMR data acquired at 600 and 150 MHz, respectively, in methanol-d4, at 300 K. s = singlet, d = doublet, t = triplet, m = multiplet, br =
broad
DOI: 10.7554/eLife.23001.013
Pateraki et al. eLife 2017;6:e23001. DOI: 10.7554/eLife.23001 8 of 28
Research article Biochemistry
Monooxygenase activity of the CYP76AH subfamily toward other
terpene scaffolds
In addition to 13R-manoyl oxide-derived diterpenoids, the root cork of C. forskohlii contains numer-
ous abietane diterpenoids derived from miltiradiene (Alasbahi and Melzig, 2010a). Recently a pair
of diterpene synthases (CfTPS1 and CfTPS3) mainly expressed in the root cork of C. forskohlii was
demonstrated to produce miltiradiene (Pateraki et al., 2014). It has been shown previously that
members of the CYP76AH subfamily in Lamiaceae are able to oxygenate miltiradiene or derivatives
thereof. CYP76AH1 from Salvia miltiorrhiza (Guo et al., 2013), CYP76AH4 as well as RoFS1 and
RoFS2 from Rosmarinus officinalis (Bozˇic´ et al., 2015; Zi and Peters, 2013) and CYP76AH24 from S.
pomifera catalyze synthesis of ferruginol, the precursor of carnosic acid and tanshinones (Guo et al.,
2013; Ignea et al., 2016a), from miltiradiene or dehydroabietadiene. Additionally, CYP76AH3 from
Table 2. Structural identification of four oxygenated 13R-manoyl oxide-derived diterpenoids formed following transient expression of
CYP encoding genes from C. forskohlii based on comparison of their 1H-NMR and 13C-NMR (Figure 4—source data 1) chemical shifts
to literature data. Chemical shifts for reference compounds marked with * have not been assigned to a specific carbon. The 13C chemi-
cal shifts of 9-deoxyforskolin (Gabetta et al., 1989) were used as reference for 6,7-dihydroxy-11-oxo-13R-manoyl oxide (7h).
9-
Deoxydeacetylforskolin
(10b)† 1,9-Dideoxydeacetylforskolin (7h)†
11-oxo-13R-manoyl
oxide (2)† Coleorol (3a)†
Pos. 1H (nH; m; J(Hz)) 13C
(Gabetta et al.,
1989) 1H (nH; m; J(Hz)) 13C
(Gabetta et al.,
1989) 13C
(Gabetta et al.,
1989) 13C
(Asada et al.,
2012)
1 4.38 (1H; t; 2.8) 71.6 71.2 2.45 (1H, d(br);
13.1)
0.78 (H; m)
41.5 43.1 42.1 41.9 31.7 31.6
2 1.47 (1H; m)
2.14 (1H; m)
25.8 25.6 1.78 (H; m)
1.40 (H; m)
18.7 18.4 18.5 18.4 18.6 18.4
3 1.12 (1H; dt; 3.4,
13.2)
1.62 (1H; dt; 3.5,
13.5)
36.4 36.3 1.36 (H; m)
1.15 (H; m)
43.8 43.7 43.4 43.3 41.9 41.8
4 34.2 34.1 34.4 34.1 33.4 33.2 33.3 33.2
5 1.34 (1H; d; 2.1) 47.5 47.4 n.d. 55.7 55.2 56.0 55.8 45.7 45.5
6 4.44 (1H; t; 2.6) 70.8 70.2 4.39 (1H; m) 70.4 70.2 19.8 19.7 19.5 19.4
7 3.68 (1H; d; 3.6) 80.7 81.1 3.71 (1H; d; 3.8) 81.0 80.7 39.6 39.4 36.6 36.4
8 80.0 78.5 80.1 79.9 77.5 77.2 78.0 77.8
9 3.32 (1H; s) 58.0 58.2 2.59 (1H; s) 65.5 65.4 66.9 66.7 75.3 75.2
10 42.2 41.7 38.0 37.8 37.3 37.1 41.1 40.9
11 207.7 207.6 206.3 205.7 207.7 207.1 21.1 21.0
12 2.63 (1H; d; 18.0)
2.69 (1H; d; 18.0)
49.8 49.9 2.60 (1H; d; 18.1)
2.66 (1H; d; 18.1)
50.0 49.8 50.4 50.2 31.6 31.5
13 75.1 74.8 75.1 75.1 75.1 74.4 72.9 72.8
14 5.94 (1H; dd; 10.8,
17.4)
146.2 145.8 5.95 (1H; dd; 10.7,
17.4)
146.9 146.4 146.9 146.0 147.4 147.3
15 5.04 (1H; d; 10.8)
5.14 (1H; d; 17.4)
112.4 112.7 5.04 (1H; d; 10.7)
5.17 (1H; d; 17.4)
112.3 112.1 112.3 111.9 110.1 110.0
16 1.30 (3H; s) 31.5 31.5* 1.28 (3H; s) 31.6 33.2* 31.4 31.2* 28.9 28.8
17 1.54 (3H; s) 24.1 24.5* 1.50 (3H; s) 23.5 31.4* 28.1 27.9* 27.0 29.9
18 1.38 (3H; s) 33.1 18.2* 0.97 (3H; s) 33.4 23.9* 15.6 15.5* 33.7 33.6
19 1.21 (3H; s) 23.7 23.6* 1.21 (3H; s) 24.0 23.7* 21.8 21.6* 21.5 21.4
20 1.01 (3H; s) 18.5 32.8* 1.30 (3H; s) 17.2 16.7* 33.6 33.5* 17.0 16.8
†1H and 13C NMR data acquired at 600 and 150 MHz, respectively,in methanol-d4, at 300 K. s = singlet, d = doublet, t = triplet, m = multiplet, br =
broad
DOI: 10.7554/eLife.23001.014
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S. miltiorrhiza has been shown to accept ferruginol as a substrate to produce sugiol, 11-hydroxy-fer-
ruginol and 11-hydroxy-sugiol (Guo et al., 2016). These miltiradiene-accepting CYP76AHs show
high-sequence homology, ranging from 60% to 85% at the amino acid level, with those identified in
C. forskohlii. Therefore, it was tempting to study the ability of the CfCYP76AHs to metabolize miltir-
adiene. The CfCYP76AHs were co-expressed individually in N. benthamiana leaves producing miltir-
adiene (Andersen-Ranberg et al., 2016), and the product profile monitored by unbiased LC-MS
analysis. CfCYP76AH15 was shown to convert miltiradiene to ferruginol (Figure 6). Ferruginol was
identified in extracts of C. forskohlii root cork (Figure 6), so it is possible that CfCYP76AH15 is also
involved in the biosynthesis of ferruginol in planta. In a parallel series of experiments, CYP76AHs
from rosemary and salvia known to accept miltiradiene as substrate were tested for their ability to
Figure 5. LC-qTOF-MS analysis of 13R-manoyl oxide-derived diterpenoids obtained by transient expression of combinations of C. forskohlii CYP
encoding genes, together with genes encoding the required enzymes for biosynthesis of 13R-manoyl oxide in N. benthamiana leaves. Total ion
chromatograms (TIC) of extracts expressing the 13R-manoyl oxide biosynthesis genes (CfCXS, CfGGPPS, CfTPS2, CfTPS3), in combination with (from
the top) water (-), CfCYP76AH8 + CfCYP76AH11 + CfCYP76AH16, CfCYP76AH17 + CfCYP76AH11 + CfCYP76AH16, and CfCYP76AH15 + CfCYP76AH11
+ CfCYP76AH16 are shown. Hydroxylated 13R-manoyl oxide-derived diterpenoids (marked with grey bars) and their identity including their molecular
formulas were confirmed by accurate mass (5 ppm tolerance, Supplementary file 1). Compounds present in trace amounts are not marked. The
identity of 1,11-dihydroxy-13R-manoyl oxide (5d), 9-deoxydeacetylforskolin (10b) and 1,9-dideoxydeacetylforskolin (7h) was confirmed by NMR analysis
(Figure 4 and Tables 1 and 2), whereas the identity of deacetylforskolin (13b) was confirmed by comparison to an authentic chemically synthesized
standard. No 13R-manoyl oxide-derived diterpenoids were identified in the water control (-). For each combinaton, extracts from leaves of three
different N. benthamiana plants have been analyzed and representative chromatograms are shown.
DOI: 10.7554/eLife.23001.015
The following figure supplement is available for figure 5:
Figure supplement 1. LC-qTOF-MS analysis of 13R-manoyl oxide-derived diterpenoids obtained by transient expression of combinations of C.
forskohlii CYP76AH encoding genes in N. benthamiana leaves.
DOI: 10.7554/eLife.23001.016
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use 13R-manoyl oxide as a substrate. Transient expression of RoCYP76AH4 (Zi and Peters, 2013),
RoFS1 and SfFS (Bozˇic´ et al., 2015) in N. benthamiana leaves able to synthesize 13R-manoyl oxide
demonstrated that RoCYP76AH4 was able to efficiently convert 13R-manoyl oxide to 11-oxo-13R-
manoyl, while RoFS1 and SfFS were able to produce 11-hydroxy manoyl oxide, in addition to 11-
oxo-13R-manoyl oxide (Figure 7).
Establishing regiospecific acetylation as the final step of forskolin
biosynthesis
To complete the biosynthetic route to forskolin, specific acetylation of the C-7 hydroxyl group of
deacetylforskolin (13b) is required. The root cork transcriptome was mined for acyltransferases
(ACTs) from clade III of the BAHD family earlier reported to predominantly use acetyl CoA as acetyl
donor for acetylation of hydroxyl groups (D’Auria, 2006). Ten ACTs (Figure 1—source data 1) were
identified, cloned and tested functionally by Agrobacterium-mediated transient expression in N.
benthamiana leaves, engineered to produce deacetylforskolin by co-expression of the enzymes
CfDXS, CfGGPPS, CfTPS2, CfTPS3, CfCYP76AH15, CfCYP76AH11 and CfCYP76AH16. Two ACT
candidates, CfACT1-6 and CfACT1-8, were found to catalyze acetylation of 13b (Figure 8). Expres-
sion of CfACT1-6 resulted in formation of a broad range of acetylated products of which forskolin
constituted a minor fraction. In contrast, CfACT1-8 exhibited high activity and specificity, with effi-
cient conversion of 13b to forskolin and absence of detectable acetylated side products. Identifica-
tion of this enzyme establishes the entire and highly specific biosynthetic route to forskolin from its
precursor, GGPP (Figure 9).
Figure 6. GC-MS analysis of miltiradiene-derived diterpenoids obtained by transient expression of CfCYP76AH15 in N. benthamiana leaves. (A) Total
ion chromatograms (TIC) of extracts transiently expressing CfCXS, CfGGPPS, CfTPS1 and CfTPS3 (miltiradiene biosynthesis genes) in combination with
water (-) or CfCYP76AH15. Dehydroabietadiene (DE) and miltiradiene (MT) were observed in the (-) extract, whereas ferruginol was observed in extracts
from tissue expressing the miltiradiene biosynthesis genes together with CfCYP76AH15. In root cork extracts, ferruginol was detected together with
dehydroabietadiene. Presence of ferruginol was confirmed by comparison to an authentic standard (Ignea et al., 2016a), while presence of miltiradiene
(B) and dehydroabietadiene (C) were confirmed by comparison of m/z spectra with previously characterized compounds (Andersen-Ranberg et al.,
2016). For every combination, extracts from leaves of three different N. benthamiana plants have been analyzed and representative chromatograms are
shown.
DOI: 10.7554/eLife.23001.017
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Engineering of the entire pathway of forskolin in Saccharomyces
cerevisiae
Expression and engineering of plant biosynthetic pathways in microbial organisms provides a
method for sustainable production of high value compounds like the structurally complex bioactive
diterpenoids (Guo et al., 2013; Ignea et al., 2016a; Jia et al., 2016). With the genes encoding the
entire biosynthetic pathway of forskolin identified, we proceeded to establish stable forskolin pro-
duction in S. cerevisiae, an excellent host organism for biosustainable and scalable production of
numerous bio-active natural products (Brochado et al., 2010; Brown et al., 2015; Galanie et al.,
2015; Hansen et al., 2009; Ignea et al., 2016a; Jeandet et al., 2012). For expression in yeast, all
C. forskohlii genes were codon-optimized and stably integrated in neutral loci in the yeast genome.
Genomic integration was chosen versus expression via episomal plasmids as the former strategy
favors the simultaneous expression of a large number of genes as well as effective selection marker
recycling (Jensen et al., 2014). Additionally, a sequence encoding a NADPH-dependent cytochrome
P450 oxidoreductase (CfPOR), required to support the P450 activity, was identified from the C. for-
skohlii root cork transcriptome and cloned for co-integration in the yeast genome. The isolated
CfPOR was the only one present in the root cork transcriptome. Genomic integration enabled stable,
simultaneous expression of a total of eight heterologous genes in the microbial host.
Figure 7. GC-MS analysis of 13R-manoyl oxide-derived diterpenoids obtained by transient expression of
CYP76AHs in N. benthamiana leaves. (A) Total ion chromatograms (TIC) of extracts transiently expressing CfCXS,
CfGGPPS, CfTPS2 and CfTPS3 (13R-manoyl oxide biosynthesis genes) in combination with water (-), CfCYP76AH15,
RoCYP76AH4, RoFS1 and SpFS are shown. 13R-manoyl oxide was observed in the (-) extracts, while 11-oxo-13R-
manoyl oxide (2) was observed in the CfCYP76AH15, RoCYP76AH4, RoFS1 and SfFS extracts. 11-Hydroxy-13R-
manoyl oxide (3d) is observed only in extracts expressing the RoFS1 and SfFS1 genes. Presence of 11-hydroxy-
13R-manoyl oxide was verified by comparison to an authentic standard (Ignea et al., 2016b) while identification of
11-oxo-13R-manoyl oxide was confirmed by comparison of m/z spectra with a previously characterized compound
(2). The results show RoCYP76AH4 has an activity similar to CfCYP76AH15, able to convert efficiently and
specifically 13R-manoyl oxide to 2. RoFS1, as well as SfFS, can also convert 13R-manoyl oxide to 2 but they
catalyze the synthesis of an additional product, 11-hydroxy-13R-manoyl oxide (3d). For every combination, extracts
from leaves of three different N. benthamiana plants have been analyzed and representative chromatograms are
shown.
DOI: 10.7554/eLife.23001.018
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CfPOR, CfCYP76AH15, CfCYP76AH11, CfCYP76AH16 and CfACT1-8 were co-expressed in the
yeast strain EFSC4498, previously engineered to produce 350 mg/L 13R-manoyl oxide (Andersen-
Ranberg et al., 2016). Transformed yeast strains verified for the integration of all forskolin biosyn-
thetic cDNAs into their genome, were further analyzed and production titers of forskolin and path-
way intermediates were monitored. The highest forskolin producing strain, EVST21543,
which demonstrated genetic stability through several rounds of cultivation, was grown in a 5 L fer-
menter using minimal medium under glucose-limited conditions. During fermentation, accumulation
of forskolin (16c), 13R-manoyl oxide (1), 9-hydroxy-13R-manoyl oxide (3a), and biomass formation
(Figure 10) were monitored over time. Forskolin levels reached more than 40 mg/L of yeast culture.
Simultaneous accumulation of high titers of 13R-manoyl oxide (1) and 9-hydroxy-13R-manoyl oxide
(3a) at levels of 200 and 500 mg/L, respectively, indicated that the conversion of 13R-manoyl oxide
(1) to forskolin was far from complete. Interestingly, these intermediates did not accumulate in the
C. forskohlii root cork. A comparison of the total intermediate profiles of C. forskohlii root cork ver-
sus the fermenter grown EVST21543 yeast strain is shown in (Figure 10—figure supplement 1).
Discussion
The terpenoid biosynthetic pathways active in the root of C. forskohlii produce an array of 13R-
manoyl oxide and miltiradiene-derived diterpenoids, including forskolin. Forskolin is one of the most
complex and highly oxygenated diterpenoids reported in C. forskohlii. In the current study, the
genes encoding the entire biosynthetic pathway for forskolin were identified. Availability of the
Figure 8. De novo biosynthesis of forskolin by transient expression of C. forskohlii genes in N. benthamiana as monitored by LC-MS-based extracted
ion chromatograms (EIC). To monitor both deacetylforskolin (13b) and forskolin (16c), the EIC were selected as the sum of m/z 433.2 ± 0.1 and m/z
391.2 ± 0.1. Chromatograms represent LC-MS analysis of extracts from leaves expressing the 13R-manoyl oxide biosynthesis genes (CfDXS, CfGGPPS,
CfTP2 and CfTPS3) in combination with (from the top): water (-); CfCYP76AH15, CfCYP76AH11 and CfCYPAH16; CfCYP76AH15, CfCYP76AH11,
CfCYPAH16 and CfACT1-6; CfCYP76AH15, CfCYP76AH11, CfCYPAH16 and CfACT1-8, shown together with authentic standards (deacetylforskolin and
forskolin). Forskolin (16c) was identified together with two other acetylated compounds (e.g. 16a, 16b) with the same molecular mass in leaves
expressing CfACT1-6 together with forskolin-specific CYPs (Supplementary file 1). When CfACT1-8 was expressed instead of CfACT1-6, a predominant
accumulation of forskolin was observed, with a drastic reduction of non-specific acetylated products. For all combinations, extracts from leaves of three
different N. benthamiana plants have been analyzed and representative chromatograms are shown.
DOI: 10.7554/eLife.23001.019
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transcriptome from the root cork cells of C. forskohlii, where forskolin biosynthesis takes place, the
option to achieve rapid functional characterization of the gene candidates in planta by transient
expression in N. benthamiana and high-sensitivity techniques for structural characterization made
the pathway elucidation possible. With the genes encoding the entire forskolin biosynthetic pathway
in hand, de novo production of forskolin in engineered yeast was achieved.
Initially, a number of genes encoding CYP76AH subfamily members, expressed mainly in the root
cork of C. forskohlii, was cloned and transiently expressed in N. benthamiana leaves being able to
produce 13R-manoyl oxide. The products profiles obtained with these enzymes revealed that
the identified CfCYP76AHs have discrete roles in forskolin biosynthesis. Efficient monooxygenation
at C-11 is catalyzed mainly by CfCYP76AH15 (but also by CfCYP76AH8, CfCYP76AH17 and CfCY-
P76AH11). Monooxygenation at position C-9 is catalyzed exclusively by CfCYP76AH16 and monoox-
ygenation at C-1, C-6 and C-7 mainly by CfCYP76AH11. Monooxygenation at C-1 was also observed
using CfCYP76AH8 and CfCYP76AH17 (4c, Figure 3—figure supplement 1). Collectively, this set of
data displays the multifunctional roles of these enzymes. Together, they could account for all the
oxygenated positions in forskolin. Co-expression of CfCYP76AH15, CfCYP76AH11 and CfCY-
P76AH16 resulted in specific and efficient formation of the final intermediate, deacetylforskolin.
Figure 9. LC-qTOF-MS analysis of 13R-manoyl oxide-derived diterpenoids obtained by transient expression of combinations of C.forskohlii CYP and
ACT encoding genes in N. benthamiana leaves. Total ion chromatograms (TIC) from extracts expressing the 13R-manoyl oxide biosynthesis genes
(CfCXS, CfGGPPS, CfTPS2, CfTPS3) in combination with (from the top) water (-), CfCYP76AH15 + CfCYP76AH11+ CfCYP76AH16 + CfACT1-6, and
CfCYP76AH15 + CfCYP76AH11 + CfCYP76AH16 + CfACT1-8 are shown. Hydroxylated and acetylated 13R-manoyl oxide-derived diterpenoids (marked
with grey bars) and their identity, including their molecular formulas, was confirmed by their accurate mass (5 ppm tolerance, Supplementary file 1).
Compounds present in trace amounts are not marked. The identity of deacetylforskolin (13b) and forskolin (16c) was confirmed by comparison to
authentic standards. No 13R-manoyl oxide-derived diterpenoids were detected in the water control ( ). For all combinations, extracts from leaves of
three different N. benthamiana plants have been analyzed and representative chromatograms are shown.
DOI: 10.7554/eLife.23001.020
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Despite the complementary multifunctionality of the CYP76AH enzymes, partial functional redun-
dancy is possible, as demonstrated by the varied oxygenation patterns observed in experiments
with single enzymes. Overlapping functionalities may contribute to a coordinated action for efficient
conversion of 1 to 13b. Moreover, certain C. forskohlii CYP76AH enzymes seem able to accept oxy-
genated forms of 1 as substrates which results in the observed shifts in profile toward higher deco-
rated products when they are co-expressed in N. benthamiana (Supplementary file 1).
Although co-expression of CfCYP76AH11 and CfCYP76AH16 with either one of the three CfCY-
P76AH8, CfCYP76AH17 or CfCYP76AH15 in the engineered system resulted in biosynthesis of
deacetylforskolin (13b) (Figure 5), the precise sequence of in planta 13R-manoyl oxide oxygenations
cannot be deduced from the experimental results partly because all identified CfCYP76AHs accept 1
as substrate. The co-expression of the CfCYP76AH encoding genes in the root cork of C. forskohlii
and their partial functional redundancy or complementarity may in vivo constitute the basis for the
chemical diversity of labdane terpenoids present in the root cork of C. forskohlii. In planta, the for-
skolin biosynthetic pathway would thus appear to be entangled within a metabolic grid offering
simultaneous production of a multitude of other diterpenoids.
Recently, CYP76AH enzymes accepting miltiradiene (a non-epoxylabdane, abietane diterpenoid,
which is also present in C. forskohlii roots) as substrate were reported from other Lamiaceae species
(Bozˇic´ et al., 2015; Guo et al., 2016; Ignea et al., 2016a; Zi and Peters, 2013). This prompted us
to examine whether the promiscuous and multifunctional CfCYP76AH could accept miltiradiene as
substrate, and vice versa, e.g. if different Lamiaceae CYP76AHs can catalyze oxygenations of 13R-
Figure 10. Forskolin production in S. cerevisiae following stable genomic integration of codon-optimized C.forskohlii genes. (A) Forskolin (16c)
accumulation in a fermenter batch using the EVST21543 strain (expressing CfCYP76AH15, CfCYP76HA11, CfCYP76AH16 and CfACT1-8 encoding genes
in the EFSC4498 S. cerevisiae strain, optimized for the production of 13R-manoyl oxide [Andersen-Ranberg et al., 2016]). (B) 13R-manoyl oxide (1)
accumulation in EVST21543 strain. (C) 9-Hydroxy-13R-manoyl oxide (3a) accumulation in EVST21543 strain. (D) EVST21543 strain biomass monitored
during the fermentation process. (E) The biosynthetic pathway used for the production of forskolin in yeast. The fermentation event occurred once, and
a triplicate of samples were analysed from each time course.
DOI: 10.7554/eLife.23001.021
The following figure supplement is available for figure 10:
Figure supplement 1. Comparison of metabolite profiles between fermenter grown yeast culture of the EVST21543 strain and C.forskohlii root extract
analyzed by LC-MS.
DOI: 10.7554/eLife.23001.022
Pateraki et al. eLife 2017;6:e23001. DOI: 10.7554/eLife.23001 15 of 28
Research article Biochemistry
manoyl oxide (Figures 6 and 7). According to our results CfCYP76AH15 was found to have very sim-
ilar catalytic activities compared to the rosemary CYP76AH4, an enzyme with a suggested role in the
oxygenation of miltiradiene toward the synthesis of ferruginol (Zi and Peters, 2013). Efficient forma-
tion of ferruginol as well as 11-oxo-13R-manoyl oxide, by both enzymes indicates that they may rep-
resent orthologues. Two additional ferruginol synthases of the CYP76AH subfamily, one from Salvia
fruticosa (SfFS) and one from Rosemary officinalis (RoFS), were found to catalyze the conversion of
13R-manoyl oxide to 11-oxo-13R-manoyl oxide and 11-hydroxy-manoyl oxide when expressed in N.
benthamiana leaves (Figures 6 and 7). These findings are not reflected in the phylogenetic analysis
of the known CYP76AHs. All C. forskohlii CYP76AHs able to produce 11-oxo-13R-manoyl oxide are
clustered together, while CYP76AHs from Salvia spp. and R. officinalis that can catalyze the forma-
tion of the same compound, as well as those CYPs able to accept miltiradiene as substrate, form a
different cluster when analyzed with currently known CYP76AHs. Thus, it is likely that the ability of
CYP76AHs to catalyze 11-oxo-13R-manoyl oxide has evolved convergently in these plants
(Figure 11).
These data highlight the functional versatility of the CYP76 family. The enzymes can exhibit broad
substrate specificity which may advance metabolic evolution as they provide metabolic plasticity and
flexibility affording synthesis of new diterpenoids. This facilitates the expansion of the number of
possible diterpenoids produced in nature and potentially serves to diversify and augment the phyto-
chemical defense of plants. The promiscuity of the CYP76AHs also provides potentials for their use
in combinatorial approaches for synthesizing a range of diterpenoids with pharmaceutical relevance.
The exclusive presence of the CYP76AH subfamily in Lamiaceae species may reflect gene duplica-
tions in a Lamiaceae ancestral species followed by expansion and neofunctionalization after specia-
tion (Figure 11).
The identification of CfACT1-8 as an ACT catalyzing regiospecific acetylation of deacetylforskolin
(13b) to afford forskolin completed the entire biosynthetic pathway for forskolin from its precursor,
GGPP. Interestingly, the only currently identified acyltransferases in diterpenoid biosynthesis are
those involved in the biosynthesis of paclitaxel. Those acetyltransferases show substantial regioselec-
tive promiscuity (Ondari and Walker, 2008; Walker and Croteau, 2000) and belong to Clade V
(D’Auria, 2006; Tuominen et al., 2011), whereas the majority of the ACTs identified in the root cork
transcriptome of C. forskohlii, including ACT1-6 and ACT1-8, belong to Clade III (Figure 12).
With all forskolin biosynthetic pathway genes identified, we moved to the generation of a stable
forskolin producing S. cerevisiae strain. To engineer a stable microbial production platform, we pro-
ceeded to integrate the minimum required set of functional parts into the S. cerevisiae genome.
Specific de novo production of the highly functionalized diterpenoid at titers above 40 mg/L was
achieved through a pathway consisting of a total of 10 enzymatic steps catalyzed by eight heterolo-
gously co-expressed enzymes. This high forskolin titer, achieved with no optimization steps, high-
lights the potential to develop a microbial manufacturing platform for efficient and stereospecific
production of forskolin with further fine-tuning of the biosynthetic pathway. Currently, it is not possi-
ble to accurately estimate the forskolin titers necessary for industrially profitable production, as the
exact commercial applications, market size and price as well as the production cost including down-
stream processing cannot be determined. Given the knowledge gained in our present study and
experiences with other compounds (Paddon and Keasling, 2014) we find it realistic to aim for yields
ranging from a single to double digits of gram per liter of yeast culture. To achieve higher forskolin
yields, it is important upfront to ascertain a proper flux toward GGPP through the mevalonate path-
way (Kampranis and Makris, 2012). Specifically for forskolin pathway, it seems clear that there is a
limitation in flux through one or several of the P450s involved as we encounter accumulation of the
intermediates, 300 mg/L and 500 mg/L of compounds 1 and 3a respectively, compared to forskolin
(40 mg/L). Accumulation of only minute amounts of deacetylforskolin shows that CfACT1-8 is not a
limiting step in the pathway. Accumulation of 1 and 3a intermediates was not observed in planta
(Figure 10—figure supplement 1). This likely signifies that the expression levels of the
heterologous CYPs expressed in yeast are not properly balanced or their efficiency and activity can
be affected negatively after incoorporation into the yeast membrane, while in the native plant host,
the pathway exhibits optimized carbon flux and enzymatic efficiency. P450s are notorious difficult to
express in high amounts in yeast and recognized as exhibiting rather low Kcat values (Jung et al.,
2011; Renault et al., 2014). Hence, to increase forskolin production in the yeast system, efforts
should obviously be focused on optimizing CfCYP76AHs expression and enzyme kinetics, specificity
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Figure 11. Phylogeny of known full-length CYP76AHs. The enzymes used are listed below with their accession numbers or source of publication:
CfCYP76AH15, KT382358; CfCYP76AH17, KT382360; CfCYP76AH8, KT382348; CfCYP76AH11, KT382349; CfCYP76AH16, KT382359; CfCYP76AH9,
KT382347; CfCYP76AH10, KT382346; CfCYP71D381, KT382342; RoFS1, AJQ30187 (Bozˇic´ et al., 2015); SmCYP76AH3, KR140168 (Guo et al., 2016);
RoFS2, AJQ30188 (Bozˇic´ et al., 2015); SfFS, AJQ30186 (Bozˇic´ et al., 2015); RoCYP76AH4, (Zi and Peters, 2013); RoCYP76AH5v1, (Zi and Peters,
2013); RoCYP76AH5v2, (Zi and Peters, 2013); RoCYP76AH6, (Zi and Peters, 2013); RoCYP76AH7, (Zi and Peters, 2013); SmCYP76AH1, AGN04215
(Guo et al., 2013); SpCYP76AH24, ALM25796 (Ignea et al., 2016a). Coleus forskohlii enzymes are indicated by a solid black triangle. CfCYP71D381
Figure 11 continued on next page
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and catalytic efficiency as well as pathway scaffolding to facilitate formation of a metabolon which
will result in improved pathway flux and efficiency and reduced accumulation of pathway intermedi-
ates (Laursen et al., 2016). The high forskolin titers already obtained though in the engineered yeast
strain highlights the potential to develop a microbial manufacturing platform for efficient and stereo-
specific production of forskolin and other labdane terpenoids by fine tuning the biosynthetic
pathways.
A yeast-based production platform constitutes a sustainable alternative to traditional crop-based
production but the gains always need to be compared to yield improvements obtained by classical
or molecular breeding of the traditional host plant (Graham et al., 2010). The model-example from
the literature and industry toward production of a pharmaceutically relevant terpenoid in S. cerevi-
siae is the sesquiterpenoid artemisinic acid, a pathway intermediate to the antimalarial compound
artemisinin (Paddon et al., 2013). However, this prominent model example is dependent on a costly
organic chemical synthesis component to chemically convert artemisinic acid to artemisinin
(Peplow, 2016). Recent approaches of engineered de novo production of structurally complex diter-
penoids, triterpenoids or alkaloids in microbial systems have also been limited to proof-of-concept
studies, expression of partial pathways and sub-milligram yields, highlighting the challenges in syn-
thetic biology to offer an economically realistic and sustainable alternative to isolation of the desired
medicinal compounds from medicinal plants bred to produce elevated levels. The constraints to
achieve high yields are connected to expression of multiple CYPs and reconstruction of pathways
with multiple functionally divergent steps (Brown et al., 2015; Li and Smolke, 2016; Zhou et al.,
2015). Strategies addressing these issues are for example the development of synthetic microbial
consortia of S. cerevisiae and E. coli, optimization of CYPS for functional expression in E. coli, optimi-
zation of interactions between the CYPs and their reductase partner and N-terminal modifications
(Biggs et al., 2016; Laursen et al., 2016; Vazquez-Albacete et al., 2017; Zhou et al., 2015).
Our current study demonstrates that mining for additional members of the CYP76AH family has
the potential to facilitate the assembly of further optimized panels of mixed-species P450s for the
biosynthesis of bioactive diterpenoids. This shows the great promise that combinatorial assembly
including CYPs outside the CYP76AH subfamily may offer and the opportunity to design production
systems for diterpenoids that are currently inaccessible due to their exclusive presence in rare or
red-listed plants and to further expand the chemical diversity of diterpenoids to production of
compounds currently not known in nature.
Materials and methods
Materials
All chemicals including forskolin were acquired from Sigma-Aldrich. An authentic standard of 13R-
manoyl oxide was prepared as previously described (Nielsen et al., 2014). CYP76AH4 (Zi and
Peters, 2013) was cloned from rosemary plants acquired at a local market in Copenhagen, Den-
mark. RoFS1 and SfFS (Bozˇic´ et al., 2015) were kindly provided by Dr. Angelos Kanellis (University
of Thessaloniki, Greece).
Chemical synthesis of deacetylforskolin
The deacetylation of forskolin has been achieved previously with the use of methanolic potassium
carbonate which can provide 7-desacetylforskolin in 65% yield (Kosley and Cherill, 1989). Here, we
carried out the deacetylation of forskolin using a solution of methanolic ammonia solution (2M) to
afford 7-desacetylforskolin quantitatively. The 1 hr NMR data of the deacetylated forskolin were in
agreement with the reported data in literature.
Figure 11 continued
was chosen as a root because it can accept 13R-manoyl oxide as a substrate, but does not catalyze the synthesis of forskolin-related products. The
number subscripts indicated at each enzyme refer to their respective enzymatic products, the structures of which are given on the right. Only the main
products of each enzymes are mentioned. MO stands for manoyl oxide.
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Transcriptome sequencing
Coleus forskohlii root cork total RNA was extracted as previously described (Pateraki et al., 2014).
RNA was prepared for sequencing using the Illumina TruSeq sample preparation kit v2 using poly-A
selection (Illumina San Diego, USA). The fragments were clustered on cBot and sequenced with
Figure 12. Phylogenetic tree of CfACT encoding candidate genes together with BAHD family acyltransferase representatives from all clades according
to D’Auria (2006). Accession numbers of the non-Coleus forskohlii selected protein sequences are shown next to the tree taxon names, while C.
forskohlii peptide accession numbers are provided in Figure 1—source data 1. The analysis only includes functionally characterized members. Coleus
forskohlii enzymes are indicated by a solid black triangle. The majority of the selected CfACTs belong to Clade III, which includes mainly members
which accept a diverse range of hydroxylated substrates and use acetyl-CoA as the main acyl donor (D’Auria, 2006). Interestingly, the ACTs known to
be involved in Taxol biosynthesis belong to Clade V.
DOI: 10.7554/eLife.23001.024
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paired ends (2  100 bp) on a HiSeq 2500 (Illumina San Diego, USA) according to the manufacturer’s
instructions. A total 106.2 million read-pairs were generated. Adaptor sequences were removed
from raw reads and reads were trimmed at the ends to phred score 20, using the fastq-mcf tool
from ea-utils (https://code.google.com/p/ea-utils/). Processed reads were assembled using Trinity
(r2013-02-16) resulting in a total of 263,652 assembled putative transcripts. Transcript abundance
estimation was performed using RSEM and the scripts provided with Trinity. Likewise, the putative
coding sequences were predicted using the TransDecoder scripts from Trinity. The high-throughput
RNA sequences reported here have been submitted to the short read archive (SRA) at the NCBI
[accession no SAMN06013363].
Identification and cloning of genes involved in forskolin biosynthesis
Mining of the C. forskohlii transcriptome database was performed as previously described
(Zerbe et al., 2013) using tBLASTx software and known CYP or acetyl transferase (ACT) sequences
as query. The identified contigs were amplified from single stranded cDNA generated from root
cork total RNA using the ‘SuperScript III First-Strand Synthesis System for RT-PCR’ (Invitrogen) and
oligo-dT primer. Cloning of the putative CYP and ACT cDNAs was achieved after PCR amplification
using gene-specific primers (Figure 1—source data 3) that were designed based on the in silico
sequences of the identified CYP and ACT contigs (Figure 1—source data 1). PCR products were
cloned into the pJET1.2 vector and verified by sequencing. For the identified non-full-length cDNAs,
(CfCYP76AH15, CfCYP76AH16 and CfACT1-8), full-length transcripts were obtained using 5’RACE
techniques.
Phylogenetic analysis of CYP76AH and ACT candidate enzymes
Amino acid sequences of the CYP76AHs of C. forskohlii and of currently available CYP76AHs from
other plant species were used to construct a phylogenetic tree to infer the evolutionary history of
these enzymes. Sequences were retrieved from the current work, GenBank database (http://www.
ncbi.nlm.nih.gov/) and original articles. Peptide alignments were performed using the MUSCLE pro-
gram included in the MEGA6 software. Phylogenetic analyses were performed by the Maximum
Likelihood method based on the Dayhoff matrix-based model with ‘uniform rates’ (Schwarz and
Dayhoff, 1979) and using all sites with ‘Nearest-Neighbor-Interchange’ heuristic method conducted
using MEGA6 software (Tamura et al., 2013). The tree is drawn to scale, with branch lengths mea-
sured in the number of substitutions per site. Bootstrap values shown in % were inferred from 1000
replicates. Branches supported by bootstrap values higher than 75% are shown.
For the phylogenetic analyses of CfACT candidates, the identified sequences from C. forskohlii
were analyzed together with BAHD family acyltransferase representatives from all clades
(D’Auria, 2006). The analysis includes only functionally characterized members. The analysis was
inferred by using the Maximum Likelihood method based on the Dayhoff matrix-based model with
‘uniform rates’ and using all sites (Schwarz and Dayhoff, 1979). Initial trees for the heuristic search
were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise
distances estimated using a JTT model, and then selecting the topology with superior log likelihood
value. The tree is drawn to scale, with branch lengths measured in the number of substitutions per
site. Evolutionary analyses were conducted using MEGA6 software (Tamura et al., 2013).
RNA extraction and quantitative real-time PCR
Total RNAs from C. forskohlii tissues were extracted as previously described (Pateraki et al., 2014)
and digested by DNase I on-column. The integrity of the RNA samples was evaluated using the
RNA-nano assay using an Agilent 2100 Bioanalyser (Agilent Technologies). First-strand cDNAs were
synthesized from 0.5 mg of total RNA from an oligo-dT primer, using the ‘SuperScript III First-Strand
Synthesis System for RT-PCR’ (Invitrogen). The resulting cDNAs were diluted 10-fold. For the qRT-
PCR reactions, gene specific primers were used (Figure 1—source data 3) with Maxima SYBR
Green/Fluorescein qPCR Master Mix (Fermentas) on a Rotor-Gene Q cycler (Qiagen) using the fol-
lowing cycling parameters: 95˚C for 7 min, 35 cycles of 95˚C for 15 s, 60˚C for 30 s and 72˚C for 30 s
followed by a melting curve cycle from 60˚C to 90˚C. Eukaryotic initiation factor 4A (TIF4a) and Elon-
gation Factor 1A (EF1a) were used as reference genes because they showed the lowest variation
across different tissues (Pateraki et al., 2014). No statistically significant differences were observed
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between the results obtained using the two different reference genes and the results presented
were normalized based on TIF4a. Relative transcript abundance was calculated as the mean of three
biological replications obtained using three different C. forskohlii plants, while the reactions were
performed in three technical replicates. Amplification efficiency was calculated with the ‘Real Time
PCR Miner’ (http://www.miner.ewindup.info/Version2). Efficiency-corrected DCT values were used to
quantify relative differences in target gene transcript accumulation. Primer specificity was assessed
by agarose gel analysis and sequencing of amplicons from representative reactions, as well as from
melting curve analysis of every reaction.
Functional characterization of Coleus forskohlii cytochrome P450
enzymes (CfCYPs) by transient expression in N. benthamiana
Functional characterization of the selected candidate genes was obtained using transient expression
in N. benthamiana which offers optimal native plant protein translation and processing, convenient
rapid and optional combinatorial co-expression of multiple genes from independent vectors, native
subcellular location of diTPS and CYPs as well as the availability of an endogenous native pathway
providing GGPP.
For the functional characterization of C. forskohlii selected CYPs and testing of their ability to
hydroxylate 13R-manoyl oxide (1), genes encoding candidate CfCYPs were transiently co-expressed
in N. benthamiana leaves together with C. forskohlii enzymes boosting the formation of 1, namely 1-
deoxy-D-xylulose 5-phosphate synthase (CfDXS), geranylgeranyl diphosphate synthase (CfGGPPS),
CfTPS2 and CfTPS3 (Pateraki et al., 2014). Transient expression in N. benthamiana was performed
as previously described (Bach et al., 2014). CfCYP cDNAs selected for functional testing were subcl-
oned into pCAMBIA130035Su by USER cloning (Nour-Eldin et al., 2010). Vectors carrying the
selected cDNAs were then transformed into the agrobacterium strain AGL-1-GC3850 (Bach et al.,
2014). For the agro-infiltration, the OD of the agrobacterium cultures of all transformed agrobacte-
ria strains was normalized to OD600 = 1. Different combinations prepared from equal volumes of
each culture of transformed agrobacterium strains expressing individual genes encoding CfCYPs or
13R-manoyl oxide biosynthetic enzymes were infiltrated into the leaves of 4–6 weeks old N. ben-
thamiana plants. Controls encompassing expression of the CfCYP encoding genes without the 13R-
manoyl oxide biosynthetic genes were used to assess the possibility of CfCYPs cross-reactivity with
tobacco endogenous diterpenoids.
Metabolites from transgenic N. benthamiana leaves were extracted by hexane and 85% MetOH
and were analyzed by GC-MS and LC-MS-qTOF, respectively. LC-MS-qTOF analysis was performed
on the system that was comprised of an Agilent G1312B SL binary pump, Agilent G1367C SL WP
autosampler, Agilent G1316B column oven, Agilent G1315C Starlight DAD detector and Bruker
microTOF II Mass Spectrometer using Electron Spray Ionization (ESI). Samples were separated on a
Synergi 2.5 mm Fusion-RP C18 column (50  3.2 mm i.d., Phenomenex Inc., Torrance, CA, USA) at a
flow rate of 0.2 mL/min with column temperature held at 25˚C. The mobile phase consisted of water
with 0.1% formic acid (v/v; solvent A) and 80% acetonitrile with 0.1% formic acid (v/v; solvent B). The
gradient program was 0 min, 60% B; 25 min, 98% B; 31 min, 98% B; 32 min, 60% B; 42 min, 60% B.
Mass spectra were acquired in positive ion mode using a drying temperature of 200˚C, a nebulizer
pressure of 3.0 bar, and a drying gas flow of 7 L/min (Luo et al., 2016).
GC-MS analysis was performed on a Shimadzu GCMS-QP2010 Ultra using a 3 Agilent HP-5MS
column (20 m  0.180 mm i.d., 0.18 mm film thickness). Injection volume and temperature was set to
1 mL and 250˚C. GC program: 60˚C for 1 min, ramp at rate 30˚C min-1 to 180˚C, ramp at rate 10˚C
min-1 to 290˚C, ramp at rate 30˚C min-1 to 320˚C and hold for 2 min. H2 was used as carrier gas.
Transfer line temperature was set to 280˚C and electron impact (EI) was used as ionization method
in the mass spectrometer (MS) with the ion source temperature and voltage set to 300˚C and 70 eV.
MS spectra were recorded from 50 m/z to 400 m/z.
Large-scale biosynthesis of oxygenated 13R-manoyl oxide compounds
for NMR analysis
11-Oxo-13R-manoyl oxide (2), 2-hydroxy-13R-manoyl oxide (3b), 19-hydroxy-13R-manoyl oxide (3c),
1,11-dihydroxy-13R-manoyl oxide (5d), 1,9-deoxydeacetylforskolin (7 hr) and 9-deoxydeacetylforsko-
lin (10b) were produced using the biosynthetic scheme described above by large-scale expression of
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the relevant gene combinations in N. benthamiana (Andersen-Ranberg et al., 2016). CYP76AH8
was expressed to obtain biosynthesis of compound (2), CYP71D381 to obtain (3b) and (3c), whereas
combined expression of CfCYP76AH8 and CfCYP76AH11 afforded (5d), (7 hr) and (10b). For the
large-scale experiments, agroinfiltration was performed by vacuum infiltration. For biosynthesis of
each compound in amounts sufficient for NMR analysis, 100–200 g of fresh weight N. benthamiana
leaf material were harvested 7 days after infiltration. Leaf material chopped into small pieces was
extracted using 0.5 L of n-hexane. The solvent was thrice evaporated and recovered by rotor evapo-
ration for repeated extraction of the same leaf material. Concentrated extracts from N. benthamiana
leaves biosynthesizing target compounds were subjected to solid phase extraction (SPE), using silica
gel with n-hexane and ethyl acetate mixtures (100:0, 99:1, 98:2, 94:6, 92:8, 88:12 (v/v)) in steps of
100 mL. Fractions containing diterpenoids were identified by GC-MS. Diterpenoid-containing frac-
tions were combined and the solvent removed by rotor evaporation and the samples resuspended
in 1 mL n-hexane affording a crude fraction for further purification.
Isolation of oxygenated 13R-manoyl oxide-derived diterpenoids from
N. benthamiana extracts
Final isolation of individual diterpenoids was achieved using an Agilent 7890B GC installed with an
Agilent 5977A MSD, GERSTEL Preparative Fraction Collector (PFC) AT 6890/7890 and a GERSTEL
CIS 4C Bundle injection port. Separation was carried out using a RESTEK Rtx-5 column (30 m  0.53
mm i.d.1 mm df) with H2 as carrier gas. At the column outlet, a splitter was mounted with a split
vent ratio of 1:100 to the MS and the PFC, respectively. Sufficient amounts of oxidized 13R-manoyl
oxide-derived diterpenoids for NMR analysis (0.5–1 mg) were obtained by 100 repeated injections
of 5 mL extract aliquots. Injection port was set in solvent vent mode with a H2 gas flow of 100 mL/
min until 0.17 min, combined with a sample injection speed of 1.5 mL/min. Purge flow was set to 3
mL/min from 0.17 min to 2.17 min. Injection temperature was held at 40˚C for 0.1 min followed by
ramping at 12˚C/s until 320˚C, which was held for 2 min. Column flow was set to 7.5 mL, which was
held constant throughout the GC program. The GC program was set to hold at 60˚C for 1 min,
ramp 30˚C/min to 220˚C, ramp 2˚C/min to 250˚C and a final ramp of 30˚C/min to 220˚C, which was
held for 2 min. Temperature of the transfer line from GC to PFC and the PFC itself was set to 250˚C.
The PFC was customized to collect the peaks of 2, 3b, 3c, 5d and 7 hr, and 10b by their retention
time identified by the MS. The MS for monitoring the PFC purification was set in scan mode from m/
z 35 to m/z 500, with a threshold of 150 ion counts. Solvent cut-off was set to 4 min and the temper-
ature of the MS source and the MS quadropole - to 300˚C and 150˚C, respectively.
Large-scale biosynthesis in S. cereviseae and isolation of 9-hydroxy-
13R-manoyl oxide (3a) for NMR analysis
For biosynthesis of 3a in amounts sufficient for NMR analysis, the S. cerevisiae strain EFSC4494 car-
rying chromosomally integrated CYP76AH16 was inoculated into a pre-culture of 5 mL selective
media (SC-Ura) and grown for 16 hr at 30˚C and 400 rpm. A 1 mL aliquot of the pre-culture was
used for inoculation of 100 mL non-selective media (SC) and grown in a 500 mL Erlenmeyer shake-
flask for 120 hr at 30˚C with horizontal shaking at 180 rpm. Following addition of 100 mL UV-grade
99.9% ethanol and maintenance of the sample at 60˚C for 20 min, 200 mL of n-hexane was added
and the sample shaken for 2 hr at room temperature. The hexane phase was concentrated by rotor
evaporation and subjected to column chromatography (dual layer Florisil/Na2SO46 mL PP SPE TUBE,
Supelco Analytical) with a gradient composed of n-hexane and 1–15% ethyl acetate.
Metabolic engineering of S. cerevisiae for the production of forskolin
All genes selected for functional expression in S. cerevisiae were codon optimized for efficient
expression in S. cerevisiae, and purchased as DNA STRINGS (Geneart, LifeTechnologies). Genomic
integration was chosen over expression via episomal plasmids to favor simultaneous expression of a
number of genes as well as to enable the use of selection marker recycling (Jensen et al., 2014).
The 13R-manoyl oxide producing S. cerevisiae strain EFSC4498 (Andersen-Ranberg et al., 2016)
was used to test all the selected gene combinations for their ability of affording synthesis of forskolin
and intermediate products. All genes were cloned into yeast genome integration plasmids by the
USER technique (Nour-Eldin et al., 2010) targeting incorporation into site XI-2 (Mikkelsen et al.,
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2012). Transformants were verified by PCR on genomic DNA for correct insertion of heterologous
genes and grown and tested in 96-deep-well plates (Andersen-Ranberg et al., 2016). The yeast
strain found to produce the highest amount of forskolin and which exhibited stability through several
cultivation rounds (EVST21543) was selected for cultivation for 140 hr in a 5 L fermenter using mini-
mal medium and glucose-limited conditions. Forskolin production was monitored using withdrawn
culture aliquots. Forskolin was extracted from the mixture of yeast cells and culture broth using 85%
methanol and incubation for 20 min at 75˚C and the extract centrifuged (10,000 g for 5 min) to pre-
cipitate yeast debris. The supernatant obtained was used after filtration for LC-MS analysis and for-
skolin quantification.
Forskolin quantification synthesized from yeast strain EVST21543
growing in the fermenter and comparison to C. forskohlii root extract
For forskolin quantification, aliquots of the yeast samples (with broth) collected at specific time
points (Figure 3) were combined with methanol to give a concentration of 85% methanol, incubated
at 75˚C for 20 min, filtered and then analyzed by LC-MS. Quantification was based on a standard cal-
ibration curve of forskolin purchased from Sigma-Aldrich. An Ultimate 3000 UHPLC+ Focused system
(Dionex Corporation, Sunnyvale, CA) coupled to a Bruker Compact ESI-QTOF-MS (Bruker Daltonik,
Bremen, Germany) was used to quantify forskolin. Samples were separated on a Kinetex XB-C18 col-
umn (100  2.1 mm i.d., 1.7 mm particle size, 100 A˚ pore size; Phenomenex Inc., Torrance, CA) main-
tained at 40˚C with a flow rate of 0.3 mL/min and mobile phase consisting of 0.05% (v/v) formic acid
in water (solvent A) and 0.05% (v/v) formic acid in acetonitrile (solvent B). The gradient LC method
used for quantification was as follows: solvent B was held at 20% for 30 s, then ramped to 100%
over 8.5 min, held at 100% for 2 min, decreased to 20% over 30 s and held for 3.5 min to give an
overall run time of 15 min. The ESI source parameters were as follows: capillary voltage, 4500 V; neb-
ulizer pressure 1.2 bar; dry gas flow, 8 l/min; dry gas temperature, 250˚C. The QTOF-MS was oper-
ated in MS only mode with collision cell energy of 7 eV and collision cell RF of 500 Vpp. Ions were
monitored in the positive mode over a range of 50–1300 m/z and spectra collected at a rate of 2 Hz.
For comparison of yeast profiles to C. forskohlii root extract, roots were grinded and then extracted
with 85% methanol, incubated at 75˚C for 30 min, filtered and analyzed by LC-MS. Analysis was per-
formed as described for forskolin quantification but with the following gradient method: 20% B for 1
min, increased to 100% B over 22 min and then returned to 20% B in 0.5 min and held for 4 min.
Quantification of 13R-manoyl oxide (1) and 9-hydroxy-13R-manoyl
oxide (3a) synthesized from yeast strain EVST21543 growing in the
fermenter
Yeast samples were collected at specific time points (Figure 10) and samples kept at  20˚C in glass
vials. For diterpenoid extraction, 500 mL of n-hexane was added to 500 mL yeast broth, shaken for 1
hr at room temperature and separated into two phases by centrifugation at 2500 rpm and stored
overnight at 4˚C. The hexane phase was then diluted 10 times and run on a SCION 436 GC-FID
(Bruker). Sample (1 mL) was injected in splitless mode at 280˚C. The GC-program was as follows:
60˚C for 1 min, ramp at 20˚C/min to 160˚C, ramp at 10˚C/min from 160˚C to 240˚C, ramp at 20˚C/
min from 240˚C to 320˚C, hold at 320˚C for 2 min. H2 was used as carrier gas with a linear flow of 50
mL/min. The FID was set at 300˚C, with N2 flow of 25 mL/min, H2 at 30 mL/min and air at 300 mL/
min. Data sampling rate was 10 Hz. Compounds 1 and 3a were identified by comparing the reten-
tion time with an authentic standard and quantification was based on FID peak area and a standard
curve of 1.
NMR analysis
All NMR experiments were recorded at 300 K in CDCl3 using a Bruker Avance III 600 MHz NMR
spectrometer (1H operating frequency 600.13 MHz) equipped with a Bruker SampleJet sample
changer and a cryogenically cooled gradient inverse triple-resonance 1.7 mm TCI probe-head
(Bruker Biospin, Rheinstetten, Germany). The experiments were acquired in automation (tempera-
ture equilibration to 300 K, optimization of lock parameters, gradient shimming, and setting of
receiver gain). Both one-dimensional 1H and 13C spectra were acquired with 30˚-pulses and 64k data
points. The 1H spectra were recorded with 3.66 s inter-pulse intervals and the FID was multiplied
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with an exponential function corresponding to line-broadening of 0.3 Hz prior to Fourier transform.
An acquisition time of 0.9 s were used for the 13C experiments with an additional relaxation delay of
2.0 s. Protons were decoupled during acquisition using waltz16 composite pulse sequence. Back-
ward linear prediction was used to correct the first complex data points of 13C FIDs before zero-fill-
ing to 128k data points and application of exponential window function with a line-broadening
factor of 1.0 Hz. Two-dimensional homo- and heteronuclear experiments were acquired with 2048
data points in the direct dimension and 128 (DQF-COSY and HMBC) or 256 (multiplicity edited
HSQC and phase sensitive NOESY) data points in the indirect dimension; with spectral widths opti-
mized from the corresponding 1H spectra. The HMBC and HSQC experiments were optimized for
nJH,C = 10 Hz and
1JH,C = 145 Hz, respectively. Acquisition and processing of NMR data were per-
formed using Topspin ver. 3.0 (Bruker Biospin GmbH), and IconNMR ver. 4.2 (Bruker Biospin GmbH)
was used for controlling automated sample change and acquisition.
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